Cano Health, Inc.: Nasdaq/NYSE listing notice — NYSE to delist Cano Health warrants (CANO/WS) due to abnormally low price; common stock unaffected

Cano Health, Inc.

NYSE notified Cano Health on Nov 9, 2023 to delist and suspend trading of warrants (CANO/WS) for 'abnormally low' prices per Section 802.01D.
Company will not appeal delisting; Form 25 filed on Nov 13, 2023 to initiate process.
Warrants expected to trade on OTC market; Class A common stock (CANO) remains listed on NYSE.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.97

Cano Health, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

Exchange: nyse
Notice: delisting notice
Rules: 802.01D

Exact text from the filing

November 9, 2023, the New York Stock Exchange (the “ NYSE ”) notified Cano Health, Inc. (the “ Company ”) that the NYSE had determined to (a) commence proceedings to delist the Company’s warrants, each whole warrant exercisable for one share of the Company’s Class A common stock, par value $0.01 per share (“ Class A Common Stock ”), at an exercise price of $1,150 per share, and listed to trade on the NYSE under the symbol “CANO/WS” (the “ Warrants ”) and (b) immediately suspend trading in the Warrants due to “abnormally low” price levels pursuant to Section 802.01D of the NYSE Listed Company M

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-277933

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.